Intrinsic value of Foghorn Therapeutics Inc. (FHTX)

Live fair value data for Foghorn Therapeutics Inc. (FHTX) is currently unavailable. Please check again shortly.

Fallback estimate (fair value API unavailable)

Intrinsic Value (Fair Value): Unlock fair value

Upside: +67.0%

Margin of Safety: +40.1%

Current Price: $174.00

Valuation: Undervalued

Confidence: 9.5/10

Visual Bar

Market Price $174.00Intrinsic Value Locked
Undervalued ✅Fair Value ⚖️Overvalued ❌

This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.

Intrinsic Value checker

Enter any ticker to open its intrinsic value analysis page.

Is Foghorn Therapeutics Inc. (FHTX) undervalued or overvalued?

Based on the current model output, Foghorn Therapeutics Inc. appears to be undervalued with a upside of 67.00%.

Fair value vs market price — Foghorn Therapeutics Inc. (FHTX)

Unlock premium access to view the live fair value comparison against current market price for FHTX.

Frequently Asked Questions - FHTX

How is FHTX intrinsic value estimated?

We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for FHTX.

Is FHTX undervalued or overvalued right now?

FHTX is currently shown as undervalued based on the difference between market price and intrinsic value.

How should I use the confidence score?

The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.

Related companies — intrinsic value

Peers for FHTX: open their intrinsic value pages.

Explore Other Stocks